Interestingly, in pancreatic cancer, PAK4 exhibited the highest frequency of alterations (10%), a notable increase compared to PAK2 (4%) and PAK3 (1%), while PAK1, PAK5, and PAK6 were altered in fewer than 1% of cases (Figure 3d). This evidence concerns the gene PAK2 and familial pancreatic carcinoma.